Phase 2 study of hyper‐CMAD with liposomal vincristine for patients with newly diagnosed acute lymphoblastic leukemia
Sasaki, Koji, Kantarjian, Hagop, Wierda, William, Ravandi‐Kashani, Farhad, Jorgensen, Jeffrey, Wang, Sa A., Khoury, Joseph, Daver, Naval, Burger, Jan, Di Nardo, Courtney D., Jain, Nitin, Short, Nicholas J., Estrov MD, Zeev, Konopleva MD, PhD, Marina, Ohanian DO, Maro, Garcia‐Manero, Guillermo, Kadia, Tapan, Alvarado‐Valero, Yesid, Yilmaz, Musa, Pierce, Sherry, Garris, Rebecca, Ingram, April, Cortes, Jorge, OʼBrien, Susan, Jabbour, Elias
Published in American journal of hematology (01.07.2020)
Published in American journal of hematology (01.07.2020)
Get full text
Journal Article
Fludarabine, Cytarabine (ARA-C) and Pegylated Erwinase (PEGCRISANTASPASE) in Patients with Relapsed or Refractory Leukemia
Almanza, Emmanuel, Bataller, Alex, Garcia-Manero, Guillermo, Maiti, Abhishek, Montalban-Bravo, Guillermo, Takahashi, Koichi, Short, Nicholas J., Jabbour, Elias, Ravandi, Farhad, Alvarado Valero, Yesid, Kadia, Tapan M.
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
A phase I study of the myeloid cell leukemia 1 (MCL1) inhibitor tapotoclax (AMG 176) in patients with myelodysplastic syndromes after hypomethylating agent failure
Chien, Kelly Sharon, Rodriguez-Sevilla, Juan Jose, Alvarado Valero, Yesid, Bravo, Guillermo Montalban, Hammond, Danielle, Swaminathan, Mahesh, Bazinet, Alexandre, Kimberley, Jacqueline, Bodden, Kristy, Schneider, Heather, Dong, Xiao Qin, Pierce, Sherry, Huang, Xuelin, Jabbour, Elias, Kantarjian, Hagop M., Garcia-Manero, Guillermo
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Results of a Phase II Study of Cladribine, Low Dose Cytarabine and Venetoclax, Alternating with Azacitidine and Venetoclax in Patients with Higher Risk Chronic Myelomonocytic Leukemia or Myelodysplastic Syndromes
Montalban-Bravo, Guillermo, Short, Nicholas J., Chien, Kelly S., Alvarado Valero, Yesid, Daver, Naval, Borthakur, Gautam, Swaminathan, Mahesh, Maiti, Abhishek, Hammond, Danielle E., Nogueras-Gonzalez, Graciela, Huang, Xuelin, Schneider, Heather, Shelly, Kristen, Kadia, Tapan M., Kantarjian, Hagop M., Garcia-Manero, Guillermo
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Updated Results from a Phase II Study of Hyper-CVAD, with or without Inotuzumab Ozogamicin, and Sequential Blinatumomab in Patients with Newly Diagnosed B-Cell Acute Lymphoblastic Leukemia
Nguyen, Daniel, Kantarjian, Hagop M., Short, Nicholas J., Jain, Nitin, Haddad, Fadi G., Yilmaz, Musa, Ferrajoli, Alessandra, Kadia, Tapan M., Alvarado Valero, Yesid, Maiti, Abhishek, Nasnas, Cedric, Nasr, Lewis, Garris, Rebecca, Konopleva, Marina Y., Ravandi, Farhad, Jabbour, Elias
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
A Phase 1 Study of the Oral CDK9 Inhibitor Voruciclib in Relapsed/Refractory (R/R) B-Cell Lymphoma (NHL) or Acute Myeloid Leukemia (AML)
Davids, Matthew S, Alvarado Valero, Yesid, Diefenbach, Catherine, Egan, Daniel N., Dinner, Shira N., Al Malki, Monzr M., Begna, Kebede, Kallam, Avyakta, Abedin, Sameem, Cook, Rachel, Javidi-Sharifi, Nathalie, Dominguez, Edward, Miao, Lu, Ghalie, Richard G, Danilov, Alexey
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
A Phase I/II Study of Combination of ASTX727, Gilteritinib and Venetoclax in Patients with Relapsed/Refractory FLT3 Mutated Acute Myeloid Leukemia (AML)
Briski, Robert, Short, Nicholas J., Daver, Naval, Kadia, Tapan M., DiNardo, Courtney D., Yilmaz, Musa, Alvarado Valero, Yesid, Vaughan, Kenneth, Pierce, Sherry, Montalbano, Kathryn, Mullin, Jillian, Kantarjian, Hagop M., Garcia-Manero, Guillermo, Ravandi, Farhad
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Update of a Phase II Trial of Guadecitabine in Higher-Risk Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Under the International Working Group 2023 Criteria
Urrutia, Samuel, Chien, Kelly S., Li, Ziyi, Borthakur, Gautam, Alvarado Valero, Yesid, Kadia, Tapan M., Kornblau, Steven M., Daver, Naval, Ravandi, Farhad, Bose, Prithviraj, Yilmaz, Musa, Ohanian, Maro, Kanagal-Shamanna, Rashmi, Bueso-Ramos, Carlos E., Kantarjian, Hagop M., Garcia-Manero, Guillermo
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
A phase II study of venetoclax (VEN) in combination with 10-day decitabine (DEC) in older/unfit pts with newly diagnosed (ND) or pts with relapsed/refractory (R/R) acute myeloid leukemia (AML), or high-risk myelodysplastic syndrome (HR-MDS)
Swaminathan, Mahesh, Dinardo, Courtney Denton, Maiti, Abhishek, Pemmaraju, Naveen, Ohanian, Maro, Daver, Naval Guastad, Garcia-Manero, Guillermo, Issa, Ghayas C., Borthakur, Gautam, Ravandi-Kashani, Farhad, Montalban-Bravo, Guillermo, Kadia, Tapan M., Alvarado Valero, Yesid, Jabbour, Elias, Short, Nicholas James, Wierda, William G., Jain, Nitin, Kornblau, Steven Mitchell, Kantarjian, Hagop M., Konopleva, Marina
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Phase I/II Study of Quizartinib, Venetoclax, and Decitabine Triple Combination in FLT3-ITD Mutated AML
Yilmaz, Musa, Muftuoglu, Muharrem, DiNardo, Courtney D., Kadia, Tapan M., Konopleva, Marina Y., Borthakur, Gautam, Pemmaraju, Naveen, Short, Nicholas J., Alvarado Valero, Yesid, Maiti, Abhishek, Masarova, Lucia, Montalban-Bravo, Guillermo, Jurisprudencia, Carissa, Pike, Allison, Loghavi, Sanam, Patel, Keyur P., Tang, Guilin, Matthews, Jairo, Kornblau, Steven M., Jabbour, Elias, Garcia-Manero, Guillermo, Ravandi, Farhad, Andreeff, Michael, Daver, Naval
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
A Phase II Study of Vibecotamab, a CD3-CD123 Bispecific T-Cell Engaging Antibody, for MDS or CMML after Hypomethylating Failure and in MRD-Positive AML
Nguyen, Daniel, Ravandi, Farhad, Wang, Sa A., Jorgensen, Jeffrey L., Wang, Wei, Chien, Kelly S., Montalban-Bravo, Guillermo, Issa, Ghayas C., Maiti, Abhishek, Alvarado Valero, Yesid, Daver, Naval, DiNardo, Courtney D., Jabbour, Elias, Kadia, Tapan M., Pemmaraju, Naveen, Yilmaz, Musa, Lee, Jaehyun, Bachireddy, Pavan, Popat, Uday R., Garcia-Manero, Guillermo, Kantarjian, Hagop M., Short, Nicholas J.
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Azacitidine Plus Venetoclax Maintenance in Acute Myeloid Leukemia Produces Sustained Remissions with Low Toxicity: Results of a Phase 2 Study
Bazinet, Alexandre, Kantarjian, Hagop M., Borthakur, Gautam, Yilmaz, Musa, Bose, Prithviraj, Jabbour, Elias, Alvarado Valero, Yesid, Chien, Kelly S., Pemmaraju, Naveen, Takahashi, Koichi, Short, Nicholas J., Daver, Naval, Issa, Ghayas C., Jain, Nitin, Hammond, Danielle E., Bull-Linderman, Debra, DiNardo, Courtney D., Burger, Jan A., Ferrajoli, Alessandra, Montalban-Bravo, Guillermo, Sasaki, Koji, Garcia-Manero, Guillermo, Ravandi, Farhad, Kadia, Tapan M.
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Mutational and Cytogenetic Dynamics at Diagnosis and Relapse in Acute Myeloid Leukemia: Influence of Intensity and Type of Treatment
Bataller, Alex, Kantarjian, Hagop M., Kadia, Tapan M., Daver, Naval, DiNardo, Courtney D., Borthakur, Gautam, Short, Nicholas J., Yilmaz, Musa, Issa, Ghayas C., Alvarado Valero, Yesid, Montalban-Bravo, Guillermo, Maiti, Abhishek, Abbas, Hussein A, Jabbour, Elias, Wierda, William G., Garcia-Manero, Guillermo, Ravandi, Farhad
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Poor Outcome of Patients with Acute Myeloid Leukemia in First Relapse Underscores the Need for Effective Initial Treatment
Bataller, Alex, Kantarjian, Hagop M., Kadia, Tapan M., Daver, Naval, DiNardo, Courtney D., Borthakur, Gautam, Short, Nicholas J., Yilmaz, Musa, Issa, Ghayas C., Alvarado Valero, Yesid, Montalban-Bravo, Guillermo, Maiti, Abhishek, Abbas, Hussein A, Jabbour, Elias, Wierda, William G., Garcia-Manero, Guillermo, Ravandi, Farhad
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Phase 2 Study of Dasatinib with and without Venetoclax in Patients with Early Chronic Phase Chronic Myeloid Leukemia (ECP-CML)
Haddad, Fadi G., Jabbour, Elias, Sasaki, Koji, Nasr, Lewis, Huang, Xuelin, Issa, Ghayas C., Ravandi, Farhad, Garcia-Manero, Guillermo, Kadia, Tapan M., Daver, Naval, Alvarado Valero, Yesid, Nasnas, Cedric, Ohanian, Maro, Short, Nicholas J., Masarova, Lucia, Zoghbi, Marianne, Nasnas, Patrice Eric, Montalban-Bravo, Guillermo, Skinner, Jeffrey, Pierce, Sherry, Andreeff, Michael, Kantarjian, Hagop M.
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Phase 2 Study of CPX-351 in Combination with Venetoclax in Patients with Newly Diagnosed, High Risk Acute Myeloid Leukemia
Jen, Wei-Ying, DiNardo, Courtney D., Chien, Kelly S., Alvarado-Valero, Yesid, Masarova, Lucia, Brandt, Mark, Bull-Linderman, Debra, Daver, Naval, Montalban-Bravo, Guillermo, Bataller, Alex, Garcia-Manero, Guillermo, Issa, Ghayas C., Alousi, Amin, Short, Nicholas J., Ravandi, Farhad, Kadia, Tapan M.
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Phase Ib/II Study (NCT02488408 / BGBC003) of Bemcentinib Monotherapy or in Combination with Cytarabine or Decitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS): FINAL Results
Loges, Sonja, Heuser, Michael, Chromik, Jolanta, Sutamtewagul, Grerk, Kapp-Schwoerer, Silke, Crugnola, Monica, Di Renzo, Nicola, Lemoli, Roberto Massimo, Mattei, Daniele Giovanni, Ben Batalla, Isabel, Waizenegger, Jonas, Janning, Melanie, Rieckmann, Lisa-Marie, Imbusch, Charles, Beumer, Niklas, Micklam, David, Gorcea-Carson, Claudia, Oliva, Cristina, Fiedler, Walter, Alvarado-Valero, Yesid, McCracken, Nigel, Gjertsen, Bjorn T.
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Phase Ib/2 Study of Oral Decitabine/Cedazuridine (ASTX727) and Venetoclax in Combination with the Targeted Mutant IDH1 Inhibitor Ivosidenib or the Targeted Mutant IDH2 Inhibitor Enasidenib: 2023 Update
Atluri, Himachandana, Mullin, Jillian, Takahashi, Koichi, Loghavi, Sanam, Maiti, Abhishek, Sasaki, Koji, Daver, Naval, Alvarado Valero, Yesid, Pemmaraju, Naveen, Borthakur, Gautam, Hammond, Danielle E., Chien, Kelly S., Ferrajoli, Alessandra, Short, Nicholas J., Abbas, Hussein A, Jabbour, Elias, Andreeff, Michael, Ravandi, Farhad, Tidwell, Rebecca S.S., Wang, Xuemei, Konopleva, Marina Y., Garcia-Manero, Guillermo, Kantarjian, Hagop M., DiNardo, Courtney D.
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Oral Decitabine/Cedazuridine with Venetoclax in High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia: Analysis By Different Response Criteria
Bataller, Alex, Montalban-Bravo, Guillermo, Bazinet, Alexandre, Alvarado Valero, Yesid, Chien, Kelly S., Venugopal, Sangeetha, Ishizawa, Jo, Hammond, Danielle E., Swaminathan, Mahesh, Sasaki, Koji, Issa, Ghayas C., Short, Nicholas J., Masarova, Lucia, Daver, Naval, Kadia, Tapan M., Colla, Simona, Qiao, Wei, Huang, Xuelin, Kanagal-Shamanna, Rashmi, Hendrickson, Stephany, Ravandi, Farhad, Jabbour, Elias, Kantarjian, Hagop, Garcia-Manero, Guillermo
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
A Phase 2 Study of the Fully Oral Combination of ASTX727 (Decitabine/Cedazuridine) Plus Venetoclax for Older and/or Unfit Patients with Acute Myeloid Leukemia
Bazinet, Alexandre, Garcia-Manero, Guillermo, Short, Nicholas J., Alvarado Valero, Yesid, Abuasab, Tareq, Islam, Md Rabiul, Montalbano, Kathryn, Issa, Ghayas C., Maiti, Abhishek, Yilmaz, Musa, Jain, Nitin, Masarova, Lucia, Kornblau, Steven M., Jabbour, Elias, Montalban-Bravo, Guillermo, Pierce, Sherry, DiNardo, Courtney D., Kadia, Tapan M., Daver, Naval, Konopleva, Marina Y., Kantarjian, Hagop M., Ravandi, Farhad
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article